The prevalence of vitexin was found to decrease viability and trigger apoptosis in A549 non-small cell lung cancer cells in vitro and in vivo, involving mitochondrial-mediated mechanisms and modulation of the PI3K/Akt/mTOR pathway [37]. Here, AKT1 is linked to non-small cell lung carcinoma.